The effect of losartan therapy on ventricular function in Marfan patients with haploinsufficient or dominant negative FBN1 mutations

A. W. den Hartog, R. Franken, M. P. van den Berg, A. H. Zwinderman, J. Timmermans, A. J. Scholte, V. de Waard, A. M. Spijkerboer, G. Pals, B. J. M. Mulder, M. Groenink*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)675-681
JournalNetherlands Heart Journal
Issue number11
Publication statusPublished - Nov 2016


  • Marfan syndrome
  • Ventricular function
  • Ventricular volumes
  • Losartan
  • Cardiac magnetic resonance imaging
  • FBN1 mutation classes

Cite this